Literature DB >> 10625453

Fluorescence assays of Cdc42 interactions with target/effector proteins.

T Nomanbhoy1, R A Cerione.   

Abstract

The goal of these studies was to examine the interactions between the GTP-binding protein Cdc42 and its target/effectors by fluorescence spectroscopy. We have inserted fluorescent reporter groups at two distinct sites on Cdc42: N-methylanthraniloyl- (Mant-) derivatized nucleotides were complexed to the nucleotide-binding site of Cdc42, while a fluorescent succinimidyl ester was covalently attached to lysine 150. These two sites are separated by about 30 A on the Cdc42 molecule. Thus, the attachment of reporter groups to these sites enables the effects of target/effector binding to be viewed over a significant portion of the GTP-binding protein surface. We have taken advantage of fluorescence changes occurring at both sites to compare the interactions of activated Cdc42 with the limit binding domains from the following target/effectors: the serine/threonine kinase PAK, the tyrosine kinase ACK-2, and the RasGAP-related protein IQGAP. In addition, a unique lysine residue on the Cdc42-binding domain of ACK-2 (GBD-ACK) was covalently modified with a fluorescent succinimidyl ester. The distances separating this reactive lysine from the nucleotide binding site and lysine 150 of Cdc42 were determined by fluorescence resonance energy transfer and yielded a picture for Cdc42/GBD-ACK interactions that is consistent with recent NMR structural determinations for Cdc42/effector complexes. The changes in reporter group fluorescence at the reactive lysine of GBD-ACK, which were induced by the binding of activated Cdc42, were also examined. Overall, the results of these studies suggest not only that Cdc42 can induce conformational changes within an effector but also that in a reciprocal fashion the target/effectors induce conformational changes that span a significant distance on the GTP-binding protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625453     DOI: 10.1021/bi9916832

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Conformational switch and role of phosphorylation in PAK activation.

Authors:  G Buchwald; E Hostinova; M G Rudolph; A Kraemer; A Sickmann; H E Meyer; K Scheffzek; A Wittinghofer
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Mechanistic studies of the autoactivation of PAK2: a two-step model of cis initiation followed by trans amplification.

Authors:  Jue Wang; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

3.  Experimental and DFT studies: novel structural modifications greatly enhance the solvent sensitivity of live cell imaging dyes.

Authors:  Alexei Toutchkine; Wen-Ge Han; Matthias Ullmann; Tiqing Liu; Donald Bashford; Louis Noodleman; Klaus M Hahn
Journal:  J Phys Chem A       Date:  2007-10-05       Impact factor: 2.781

4.  Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).

Authors:  Mamta Jaiswal; Lothar Gremer; Radovan Dvorsky; Lars Christian Haeusler; Ion C Cirstea; Katharina Uhlenbrock; Mohammad Reza Ahmadian
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

5.  Regulation of protein transport from the Golgi complex to the endoplasmic reticulum by CDC42 and N-WASP.

Authors:  Ana Luna; Olga B Matas; José Angel Martínez-Menárguez; Eugenia Mato; Juan M Durán; José Ballesta; Michael Way; Gustavo Egea
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

6.  IQGAP1 Interaction with RHO Family Proteins Revisited: KINETIC AND EQUILIBRIUM EVIDENCE FOR MULTIPLE DISTINCT BINDING SITES.

Authors:  Kazem Nouri; Eyad K Fansa; Ehsan Amin; Radovan Dvorsky; Lothar Gremer; Dieter Willbold; Lutz Schmitt; David J Timson; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-11-04       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.